论文信息 - CD 30 Ligand Is a Target for a Novel Biological Therapy against Colitis Associated with Th 17 Responses - 字舞流文

CD 30 Ligand Is a Target for a Novel Biological Therapy against Colitis Associated with Th 17 Responses

Y. Iwakura | Hisakata Yamada | Y. Yoshikai | E. Podack | K. Tani | K. Shibata | H. Muta | Xun Sun | H. Yamada